MONTREAL–Institut Rosell-Lallemand’s Probio’Stick® expanded into new territories with launches in France and Mexico by the company’s local partners Urgo and medix®, respectively. Probio’Stick (a combination of Lactobacillus Rosell-52 and Bifidobacterium Rosell-175) is already marketed in several markets around the world: China (with Minsheng pharmaceutical), Canada (distributed by Jamieson Laboratories), Scandinavia (with Baltex) and Portugal (with Prisfar).
In France, Urgo markets the formula as ImmunoStim® Stress, as part of its new ImmunoStim full range of probiotics, sold through pharmacies. In Mexico, Probio’Stick is sold under trade mark Senex 3®. Medix® organized a launch tour in early November, gathering several hundreds gastroenterologists and internists.
Probio’Stick is backed by two clinical studies showing its efficacy on both physical and psychological symptoms of stress and anxiety. A clinical trial, published in 2008 showed the preparation’s efficacy to alleviate gastrointestinal symptoms linked to stress in chronic stress sufferers, mainly abdominal pain and nausea. In 2010, a study concluded the probiotic had beneficial effects on general signs of anxiety and depression, and to improve one’s ability to cope with the stress of everyday’s life events.
